Axcella Health Stock Price, News & Analysis

AXLA NASDAQ

Company Description

Axcella Health (NASDAQ: AXLA) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

AXLA stock has declined 100.0% over the past year.

This page provides a comprehensive overview of AXLA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

2.9M

Shares outstanding

Axcella Health (AXLA) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

September 14, 2023

-38.23%

Axcella Announces Reverse Stock Split Effective September 19, 2023

stock split

August 29, 2023

+298.94%

Axcella Granted Patent for Long COVID Fatigue Treatment

covid-19

August 3, 2023

+0.16%

Axcella Reports Second Quarter Financial Results and Provides Business Update

earnings

May 4, 2023

+1.27%

Axcella Reports First Quarter Financial Results and Provides Business Update

earnings

April 17, 2023

-6.91%

Axcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023

covid-19

March 30, 2023

+15.52%

Axcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

earnings

Axcella Health has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include stock split, covid-19, earnings, clinical trial, fda approval. View all AXLA news →

SEC Filings

View All

No SEC filings available for AXLA.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

AXLA Company Profile & Sector Positioning

Axcella Health (AXLA) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.